Project Details
Description
A pilot randomized, double-blind, placebo-controlled trial of caspfungin empirical therapy for invasive candidiasis in high-risk adults in the critical care settings
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/10 → 12/31/20 |
Funding
- MERCK AND CO INC